Is dizziness a common side effect of Symbicort (budesonide/formoterol)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Is Dizziness a Common Side Effect of Symbicort?

Dizziness is NOT a common side effect of Symbicort, but it is a recognized adverse reaction that has been reported in post-marketing surveillance.

Frequency Classification

According to the FDA drug label, dizziness does not appear in the table of adverse events occurring at ≥3% incidence in clinical trials 1. The most common adverse events (≥3%) in COPD trials were:

  • Nasopharyngitis (7.3%)
  • Oral candidiasis (6.0%)
  • Bronchitis (5.4%)
  • Sinusitis (3.5%)
  • Upper respiratory tract infection (3.5%)

Post-Marketing Reports

Dizziness is listed as a post-marketing adverse reaction under "Nervous system disorders" 1. This means it has been reported voluntarily after drug approval, but the frequency cannot be reliably estimated because:

  • Reports come from an uncertain population size
  • Causality cannot always be definitively established
  • It occurs rarely enough that it wasn't detected in controlled clinical trials

Mechanism and Context

The dizziness associated with Symbicort likely relates to the formoterol component (the long-acting beta-agonist), which can cause:

  • Tremor
  • Nervousness
  • Tachycardia
  • Hypokalemia

These beta-agonist effects may contribute to dizziness, particularly in cases of overdose or excessive dosing 1.

Recent Pharmacovigilance Data

A 2026 real-world safety analysis using multiple adverse event databases identified dizziness as an unexpected signal, though the study emphasized that continuous monitoring is needed, especially during early treatment 2.

Clinical Implications

  • Dizziness should not be expected as a routine side effect
  • If a patient reports dizziness on Symbicort, consider:
    • Medication timing and dosing accuracy
    • Concurrent medications (especially beta-blockers, MAO inhibitors, tricyclic antidepressants, or diuretics) 1
    • Cardiovascular status, particularly in elderly patients
    • Other causes unrelated to Symbicort

Bottom line: While dizziness can occur with Symbicort, it is uncommon and should prompt evaluation for other contributing factors or alternative diagnoses.

Related Questions

What is the appropriate management for an asthmatic patient on budesonide/formoterol (Symbicort) who reports an impending cough and coughing fits after previous pneumonia treatment?
What is the equivalent Symbicort (budesonide/formoterol) strength for a patient currently using Trilogy Elliptic 100 6.2 25?
What is the difference between Foracort (budesonide and formoterol) and Duolin (ipratropium and salbutamol) in treating asthma or Chronic Obstructive Pulmonary Disease (COPD)?
How should Symbicort (budesonide/formoterol) be used in a patient with hypo‑osmolality and hyponatraemia?
For an adult with asthma currently using Advair Diskus (fluticasone 250 µg/salmeterol 50 µg) 1 puff twice daily, is it appropriate to switch to or add Breztri (budesonide/formoterol/glycopyrrolate) and what are the recommendations?
How should Celestone Soluspan (betamethasone) be prepared for a knee injection?
In a patient with osteoporosis who has an elevated alkaline phosphatase, what does this indicate and how should it be managed?
What are the updated target blood glucose ranges for diabetic patients for fasting, random, and post‑prandial measurements?
A 66-year-old patient, six weeks post open reduction internal fixation (ORIF) of a lateral malleolus fracture and ankle syndesmosis fixation, what is the expected recovery timeline and which healthcare providers should she follow up with?
What are the administration instructions for the Abilify (aripiprazole) injectable depot formulations?
Should a patient with MRSA pneumonia be placed on isolation precautions?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.